Brief: Caredx And Miromatrix Announce Exclusive Partnership To Advance Research Using Bioengineered Organs For Human Transplantation
05/04/2023 12:06
April 5 (Reuters) - CareDx Inc CDNA.O :
* CAREDX AND MIROMATRIX ANNOUNCE EXCLUSIVE PARTNERSHIP TO
ADVANCE
RESEARCH USING BIOENGINEERED ORGANS FOR HUMAN TRANSPLANTATION
* CAREDX INC - CAREDX EXCLUSIVE PROVIDER OF DD-CFDNA TESTING
SERVICES FOR USE IN MIROMATRIX CLINICAL TRIALS
Source text for Eikon: ID:nGNXc1jQG7
Further company coverage: CDNA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23